Non-sterile Powder Free Nitrile Examination Glove, Dual Color (White-Green), Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, Xylazine HCl, and Simulated Gastric Acid; Non-sterile Powder Free Nitrile Examination Glove, Dual Color (White-Blue), Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, Xylazine HCl, and Simulated Gastric Acid
Kossan International Sdn Bhd · Decision date Jan 13, 2026
What did the FDA decide?
FDA records K252549 as a 510(k) premarket notification, with a decision dated Jan 13, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Jan 13, 2026
Regulatory record facts
- Identifier
- K252549
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Kossan International Sdn Bhd
- Product code
- LZA
- Decision code
- SESE
- Decision date
- Jan 13, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Polymer Patient Examination Glove.
- Applicant
- Kossan International Sdn Bhd
- Product code
- LZA
- FDA device class
- 1
FDA decision timeline
K252549 received
Application receipt date recorded by FDA.
K252549 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LZA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Vietglove Corporation | 510(k) clearance | Oct 29, 2026 | FDA | |
| Yty Industry (Manjung) Sdn Bhd | 510(k) clearance | Oct 1, 2026 | FDA | |
| Maxter Healthcare, Inc. | 510(k) clearance | Sep 9, 2026 | FDA | |
| Top Glove Sdn. Bhd. | 510(k) clearance | Sep 9, 2026 | FDA | |
| Gmp Medicare Sdn. Bhd. | 510(k) clearance | Sep 8, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Kossan International Sdn Bhd
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shah Alam
Sources and methodology
- Original FDA record: K252549
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records